Table 4.
The pooled results of Baduanjin exercise for plasma LDL-C level in healthy participants or clinical patients.
| Group | Numbers of comparisons | n/T | n/C | MD (95% CI) (mmol/L) |
P value | I 2 (%) | P heterogeneity |
|---|---|---|---|---|---|---|---|
| Baduanjin + routine treatment versus routine treatment | |||||||
| Clinical patients | 3 | 88 | 88 | 0.14 (−0.03, 0.31) | P = 0.1 | 60 | P = 0.08 |
| Baduanjin versus no treatment | |||||||
| Clinical patients | 2 | 38 | 35 | −0.38 (−0.63, −0.13) | P = 0.002 | 0 | P = 0.62 |
| Healthy participants | 9 | 140 | 144 | −0.35 (−0.54, −0.17) | P = 0.0002 | 47 | P = 0.05 |
| Baduanjin versus other exercises | |||||||
| Healthy participants | 2 | 49 | 47 | 0.08 (−0.07, 0.23) | P = 0.28 | 74 | P = 0.05 |
| Baduanjin + routine treatment versus other exercises + routine treatment | |||||||
| Clinical patients | 3 | 114 | 106 | 0.08 (−0.43, 0.58) | P = 0.76 | 88 | P = 0.0003 |
T: The treatment group, C: The control group.